000 01322 a2200409 4500
005 20250512084445.0
264 0 _c19850731
008 198507s 0 0 eng d
022 _a0007-1161
024 7 _a10.1136/bjo.69.6.425
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHuber, M J
245 0 0 _aMydriatic drugs for diabetic patients.
_h[electronic resource]
260 _bThe British journal of ophthalmology
_cJun 1985
300 _a425-7 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAccommodation, Ocular
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aDiabetes Mellitus
_xphysiopathology
650 0 4 _aDiabetic Retinopathy
_xphysiopathology
650 0 4 _aDrug Synergism
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aLaser Therapy
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPhenylephrine
_xpharmacology
650 0 4 _aPupil
_xdrug effects
650 0 4 _aPyridines
_xpharmacology
650 0 4 _aTropicamide
_xpharmacology
700 1 _aSmith, S A
700 1 _aSmith, S E
773 0 _tThe British journal of ophthalmology
_gvol. 69
_gno. 6
_gp. 425-7
856 4 0 _uhttps://doi.org/10.1136/bjo.69.6.425
_zAvailable from publisher's website
999 _c4045629
_d4045629